Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4586)
All Articles published online
|
Publishing Process of This Article
|
Jun 26, 2014 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Methodology
ISSN
2222-0682
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Colloca G, Venturino A, Governato I. End points of clinical trials in metastatic castration-resistant prostate cancer: A systematic review. World J Methodol 2014; 4(2): 123-132 [PMID: 25332911 DOI: 10.5662/wjm.v4.i2.123] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v4/i2/123.htm |
| Number | Citing Articles |
| 1 |
William K. Oh, Raymond Miao, Francis Vekeman, Jennifer Sung, Wendy Y. Cheng, Marjolaine Gauthier-Loiselle, Ravinder Dhawan, Mei Sheng Duh. Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting. Clinical Genitourinary Cancer 2018; 16(1): 50 doi: 10.1016/j.clgc.2017.06.004
|